nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—ABCG2—Dactinomycin—sarcoma	0.0943	0.119	CbGbCtD
Buprenorphine—ABCG2—Mitoxantrone—sarcoma	0.0844	0.107	CbGbCtD
Buprenorphine—ABCG2—Vincristine—sarcoma	0.0581	0.0734	CbGbCtD
Buprenorphine—ABCG2—Etoposide—sarcoma	0.0532	0.0672	CbGbCtD
Buprenorphine—CYP1A2—Dacarbazine—sarcoma	0.0448	0.0567	CbGbCtD
Buprenorphine—CYP3A7—Vincristine—sarcoma	0.0429	0.0542	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0429	0.0542	CbGbCtD
Buprenorphine—CYP3A4—Thiotepa—sarcoma	0.0424	0.0536	CbGbCtD
Buprenorphine—ABCG2—Doxorubicin—sarcoma	0.0363	0.0459	CbGbCtD
Buprenorphine—ABCB1—Dactinomycin—sarcoma	0.034	0.043	CbGbCtD
Buprenorphine—CYP3A5—Vincristine—sarcoma	0.0322	0.0407	CbGbCtD
Buprenorphine—ABCB1—Mitoxantrone—sarcoma	0.0304	0.0385	CbGbCtD
Buprenorphine—CYP3A5—Etoposide—sarcoma	0.0295	0.0373	CbGbCtD
Buprenorphine—CYP2C8—Etoposide—sarcoma	0.0283	0.0358	CbGbCtD
Buprenorphine—CYP1A2—Etoposide—sarcoma	0.0219	0.0277	CbGbCtD
Buprenorphine—ABCB1—Vincristine—sarcoma	0.0209	0.0265	CbGbCtD
Buprenorphine—ABCB1—Etoposide—sarcoma	0.0192	0.0242	CbGbCtD
Buprenorphine—CYP3A4—Mitoxantrone—sarcoma	0.0182	0.023	CbGbCtD
Buprenorphine—ABCB1—Doxorubicin—sarcoma	0.0131	0.0165	CbGbCtD
Buprenorphine—CYP3A4—Vincristine—sarcoma	0.0125	0.0159	CbGbCtD
Buprenorphine—CYP2D6—Doxorubicin—sarcoma	0.0123	0.0156	CbGbCtD
Buprenorphine—CYP3A4—Etoposide—sarcoma	0.0115	0.0145	CbGbCtD
Buprenorphine—Naloxone—CREB1—sarcoma	0.00788	1	CrCbGaD
Buprenorphine—CYP3A4—Doxorubicin—sarcoma	0.00784	0.00991	CbGbCtD
Buprenorphine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000271	0.00135	CcSEcCtD
Buprenorphine—Abdominal pain upper—Doxorubicin—sarcoma	0.000271	0.00135	CcSEcCtD
Buprenorphine—Angina pectoris—Epirubicin—sarcoma	0.00027	0.00134	CcSEcCtD
Buprenorphine—Urticaria—Mitoxantrone—sarcoma	0.000269	0.00134	CcSEcCtD
Buprenorphine—Breast disorder—Doxorubicin—sarcoma	0.000268	0.00134	CcSEcCtD
Buprenorphine—Anorexia—Etoposide—sarcoma	0.000268	0.00133	CcSEcCtD
Buprenorphine—Diarrhoea—Thiotepa—sarcoma	0.000268	0.00133	CcSEcCtD
Buprenorphine—Body temperature increased—Mitoxantrone—sarcoma	0.000267	0.00133	CcSEcCtD
Buprenorphine—Abdominal pain—Mitoxantrone—sarcoma	0.000267	0.00133	CcSEcCtD
Buprenorphine—Bronchitis—Epirubicin—sarcoma	0.000267	0.00133	CcSEcCtD
Buprenorphine—Diarrhoea—Dactinomycin—sarcoma	0.000266	0.00132	CcSEcCtD
Buprenorphine—Nasopharyngitis—Doxorubicin—sarcoma	0.000266	0.00132	CcSEcCtD
Buprenorphine—Hypotension—Etoposide—sarcoma	0.000263	0.00131	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000262	0.0013	CcSEcCtD
Buprenorphine—Muscular weakness—Doxorubicin—sarcoma	0.000262	0.0013	CcSEcCtD
Buprenorphine—Dizziness—Thiotepa—sarcoma	0.000259	0.00129	CcSEcCtD
Buprenorphine—Abdominal distension—Doxorubicin—sarcoma	0.000258	0.00129	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000258	0.00128	CcSEcCtD
Buprenorphine—Influenza—Doxorubicin—sarcoma	0.000257	0.00128	CcSEcCtD
Buprenorphine—Dysphagia—Doxorubicin—sarcoma	0.000257	0.00128	CcSEcCtD
Buprenorphine—Asthma—Doxorubicin—sarcoma	0.000257	0.00128	CcSEcCtD
Buprenorphine—Hypersensitivity—Vincristine—sarcoma	0.000256	0.00127	CcSEcCtD
Buprenorphine—Paraesthesia—Etoposide—sarcoma	0.000253	0.00126	CcSEcCtD
Buprenorphine—Weight decreased—Epirubicin—sarcoma	0.000251	0.00125	CcSEcCtD
Buprenorphine—Dyspnoea—Etoposide—sarcoma	0.000251	0.00125	CcSEcCtD
Buprenorphine—Somnolence—Etoposide—sarcoma	0.00025	0.00125	CcSEcCtD
Buprenorphine—Angina pectoris—Doxorubicin—sarcoma	0.00025	0.00124	CcSEcCtD
Buprenorphine—Hypersensitivity—Mitoxantrone—sarcoma	0.000249	0.00124	CcSEcCtD
Buprenorphine—Asthenia—Vincristine—sarcoma	0.000249	0.00124	CcSEcCtD
Buprenorphine—Vomiting—Thiotepa—sarcoma	0.000249	0.00124	CcSEcCtD
Buprenorphine—Infestation—Epirubicin—sarcoma	0.000247	0.00123	CcSEcCtD
Buprenorphine—Infestation NOS—Epirubicin—sarcoma	0.000247	0.00123	CcSEcCtD
Buprenorphine—Vomiting—Dactinomycin—sarcoma	0.000247	0.00123	CcSEcCtD
Buprenorphine—Rash—Thiotepa—sarcoma	0.000247	0.00123	CcSEcCtD
Buprenorphine—Bronchitis—Doxorubicin—sarcoma	0.000247	0.00123	CcSEcCtD
Buprenorphine—Dermatitis—Thiotepa—sarcoma	0.000247	0.00123	CcSEcCtD
Buprenorphine—Headache—Thiotepa—sarcoma	0.000245	0.00122	CcSEcCtD
Buprenorphine—Rash—Dactinomycin—sarcoma	0.000245	0.00122	CcSEcCtD
Buprenorphine—Decreased appetite—Etoposide—sarcoma	0.000245	0.00122	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Etoposide—sarcoma	0.000243	0.00121	CcSEcCtD
Buprenorphine—Asthenia—Mitoxantrone—sarcoma	0.000243	0.00121	CcSEcCtD
Buprenorphine—Fatigue—Etoposide—sarcoma	0.000243	0.00121	CcSEcCtD
Buprenorphine—Pain—Etoposide—sarcoma	0.000241	0.0012	CcSEcCtD
Buprenorphine—Constipation—Etoposide—sarcoma	0.000241	0.0012	CcSEcCtD
Buprenorphine—Urinary tract infection—Epirubicin—sarcoma	0.00024	0.0012	CcSEcCtD
Buprenorphine—Conjunctivitis—Epirubicin—sarcoma	0.00024	0.0012	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000239	0.00119	CcSEcCtD
Buprenorphine—Diarrhoea—Vincristine—sarcoma	0.000238	0.00118	CcSEcCtD
Buprenorphine—Sweating—Epirubicin—sarcoma	0.000237	0.00118	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Epirubicin—sarcoma	0.000234	0.00116	CcSEcCtD
Buprenorphine—Nausea—Thiotepa—sarcoma	0.000233	0.00116	CcSEcCtD
Buprenorphine—Weight decreased—Doxorubicin—sarcoma	0.000232	0.00116	CcSEcCtD
Buprenorphine—Sinusitis—Epirubicin—sarcoma	0.000232	0.00115	CcSEcCtD
Buprenorphine—Feeling abnormal—Etoposide—sarcoma	0.000232	0.00115	CcSEcCtD
Buprenorphine—Diarrhoea—Mitoxantrone—sarcoma	0.000231	0.00115	CcSEcCtD
Buprenorphine—Nausea—Dactinomycin—sarcoma	0.000231	0.00115	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Etoposide—sarcoma	0.00023	0.00115	CcSEcCtD
Buprenorphine—Dizziness—Vincristine—sarcoma	0.00023	0.00114	CcSEcCtD
Buprenorphine—Infestation NOS—Doxorubicin—sarcoma	0.000229	0.00114	CcSEcCtD
Buprenorphine—Infestation—Doxorubicin—sarcoma	0.000229	0.00114	CcSEcCtD
Buprenorphine—Bradycardia—Epirubicin—sarcoma	0.000226	0.00112	CcSEcCtD
Buprenorphine—Urticaria—Etoposide—sarcoma	0.000224	0.00111	CcSEcCtD
Buprenorphine—Rhinitis—Epirubicin—sarcoma	0.000223	0.00111	CcSEcCtD
Buprenorphine—Body temperature increased—Etoposide—sarcoma	0.000222	0.00111	CcSEcCtD
Buprenorphine—Abdominal pain—Etoposide—sarcoma	0.000222	0.00111	CcSEcCtD
Buprenorphine—Urinary tract infection—Doxorubicin—sarcoma	0.000222	0.00111	CcSEcCtD
Buprenorphine—Conjunctivitis—Doxorubicin—sarcoma	0.000222	0.00111	CcSEcCtD
Buprenorphine—Hypoaesthesia—Epirubicin—sarcoma	0.000221	0.0011	CcSEcCtD
Buprenorphine—Vomiting—Vincristine—sarcoma	0.000221	0.0011	CcSEcCtD
Buprenorphine—Pharyngitis—Epirubicin—sarcoma	0.00022	0.0011	CcSEcCtD
Buprenorphine—Sweating—Doxorubicin—sarcoma	0.000219	0.00109	CcSEcCtD
Buprenorphine—Urinary tract disorder—Epirubicin—sarcoma	0.000219	0.00109	CcSEcCtD
Buprenorphine—Rash—Vincristine—sarcoma	0.000219	0.00109	CcSEcCtD
Buprenorphine—Dermatitis—Vincristine—sarcoma	0.000219	0.00109	CcSEcCtD
Buprenorphine—Oedema peripheral—Epirubicin—sarcoma	0.000219	0.00109	CcSEcCtD
Buprenorphine—Connective tissue disorder—Epirubicin—sarcoma	0.000218	0.00109	CcSEcCtD
Buprenorphine—Urethral disorder—Epirubicin—sarcoma	0.000218	0.00108	CcSEcCtD
Buprenorphine—Headache—Vincristine—sarcoma	0.000218	0.00108	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000216	0.00108	CcSEcCtD
Buprenorphine—Vomiting—Mitoxantrone—sarcoma	0.000215	0.00107	CcSEcCtD
Buprenorphine—Sinusitis—Doxorubicin—sarcoma	0.000215	0.00107	CcSEcCtD
Buprenorphine—Visual impairment—Epirubicin—sarcoma	0.000214	0.00106	CcSEcCtD
Buprenorphine—Rash—Mitoxantrone—sarcoma	0.000213	0.00106	CcSEcCtD
Buprenorphine—Dermatitis—Mitoxantrone—sarcoma	0.000213	0.00106	CcSEcCtD
Buprenorphine—Headache—Mitoxantrone—sarcoma	0.000212	0.00105	CcSEcCtD
Buprenorphine—Bradycardia—Doxorubicin—sarcoma	0.000209	0.00104	CcSEcCtD
Buprenorphine—Eye disorder—Epirubicin—sarcoma	0.000207	0.00103	CcSEcCtD
Buprenorphine—Hypersensitivity—Etoposide—sarcoma	0.000207	0.00103	CcSEcCtD
Buprenorphine—Tinnitus—Epirubicin—sarcoma	0.000207	0.00103	CcSEcCtD
Buprenorphine—Nausea—Vincristine—sarcoma	0.000206	0.00103	CcSEcCtD
Buprenorphine—Flushing—Epirubicin—sarcoma	0.000206	0.00103	CcSEcCtD
Buprenorphine—Cardiac disorder—Epirubicin—sarcoma	0.000206	0.00103	CcSEcCtD
Buprenorphine—Rhinitis—Doxorubicin—sarcoma	0.000206	0.00102	CcSEcCtD
Buprenorphine—Hypoaesthesia—Doxorubicin—sarcoma	0.000204	0.00102	CcSEcCtD
Buprenorphine—Pharyngitis—Doxorubicin—sarcoma	0.000204	0.00101	CcSEcCtD
Buprenorphine—Urinary tract disorder—Doxorubicin—sarcoma	0.000203	0.00101	CcSEcCtD
Buprenorphine—Oedema peripheral—Doxorubicin—sarcoma	0.000202	0.00101	CcSEcCtD
Buprenorphine—Asthenia—Etoposide—sarcoma	0.000202	0.001	CcSEcCtD
Buprenorphine—Connective tissue disorder—Doxorubicin—sarcoma	0.000202	0.001	CcSEcCtD
Buprenorphine—Angiopathy—Epirubicin—sarcoma	0.000201	0.001	CcSEcCtD
Buprenorphine—Urethral disorder—Doxorubicin—sarcoma	0.000201	0.001	CcSEcCtD
Buprenorphine—Nausea—Mitoxantrone—sarcoma	0.000201	0.001	CcSEcCtD
Buprenorphine—Immune system disorder—Epirubicin—sarcoma	0.000201	0.000998	CcSEcCtD
Buprenorphine—Mediastinal disorder—Epirubicin—sarcoma	0.0002	0.000996	CcSEcCtD
Buprenorphine—Chills—Epirubicin—sarcoma	0.000199	0.000991	CcSEcCtD
Buprenorphine—Pruritus—Etoposide—sarcoma	0.000199	0.000991	CcSEcCtD
Buprenorphine—Visual impairment—Doxorubicin—sarcoma	0.000198	0.000985	CcSEcCtD
Buprenorphine—Mental disorder—Epirubicin—sarcoma	0.000195	0.000968	CcSEcCtD
Buprenorphine—Malnutrition—Epirubicin—sarcoma	0.000193	0.000962	CcSEcCtD
Buprenorphine—Erythema—Epirubicin—sarcoma	0.000193	0.000962	CcSEcCtD
Buprenorphine—Diarrhoea—Etoposide—sarcoma	0.000193	0.000958	CcSEcCtD
Buprenorphine—Eye disorder—Doxorubicin—sarcoma	0.000192	0.000955	CcSEcCtD
Buprenorphine—Tinnitus—Doxorubicin—sarcoma	0.000192	0.000953	CcSEcCtD
Buprenorphine—Flushing—Doxorubicin—sarcoma	0.000191	0.000949	CcSEcCtD
Buprenorphine—Cardiac disorder—Doxorubicin—sarcoma	0.000191	0.000949	CcSEcCtD
Buprenorphine—Flatulence—Epirubicin—sarcoma	0.00019	0.000948	CcSEcCtD
Buprenorphine—Tension—Epirubicin—sarcoma	0.00019	0.000944	CcSEcCtD
Buprenorphine—Dysgeusia—Epirubicin—sarcoma	0.000189	0.000942	CcSEcCtD
Buprenorphine—Nervousness—Epirubicin—sarcoma	0.000188	0.000934	CcSEcCtD
Buprenorphine—Back pain—Epirubicin—sarcoma	0.000187	0.00093	CcSEcCtD
Buprenorphine—Angiopathy—Doxorubicin—sarcoma	0.000186	0.000928	CcSEcCtD
Buprenorphine—Dizziness—Etoposide—sarcoma	0.000186	0.000926	CcSEcCtD
Buprenorphine—Muscle spasms—Epirubicin—sarcoma	0.000186	0.000925	CcSEcCtD
Buprenorphine—Immune system disorder—Doxorubicin—sarcoma	0.000186	0.000923	CcSEcCtD
Buprenorphine—Mediastinal disorder—Doxorubicin—sarcoma	0.000185	0.000921	CcSEcCtD
Buprenorphine—Chills—Doxorubicin—sarcoma	0.000184	0.000917	CcSEcCtD
Buprenorphine—Vision blurred—Epirubicin—sarcoma	0.000182	0.000907	CcSEcCtD
Buprenorphine—Mental disorder—Doxorubicin—sarcoma	0.00018	0.000896	CcSEcCtD
Buprenorphine—Ill-defined disorder—Epirubicin—sarcoma	0.000179	0.000892	CcSEcCtD
Buprenorphine—Vomiting—Etoposide—sarcoma	0.000179	0.00089	CcSEcCtD
Buprenorphine—Malnutrition—Doxorubicin—sarcoma	0.000179	0.00089	CcSEcCtD
Buprenorphine—Erythema—Doxorubicin—sarcoma	0.000179	0.00089	CcSEcCtD
Buprenorphine—Agitation—Epirubicin—sarcoma	0.000178	0.000884	CcSEcCtD
Buprenorphine—Rash—Etoposide—sarcoma	0.000177	0.000883	CcSEcCtD
Buprenorphine—Dermatitis—Etoposide—sarcoma	0.000177	0.000882	CcSEcCtD
Buprenorphine—Headache—Etoposide—sarcoma	0.000176	0.000877	CcSEcCtD
Buprenorphine—Flatulence—Doxorubicin—sarcoma	0.000176	0.000877	CcSEcCtD
Buprenorphine—Tension—Doxorubicin—sarcoma	0.000175	0.000873	CcSEcCtD
Buprenorphine—Dysgeusia—Doxorubicin—sarcoma	0.000175	0.000872	CcSEcCtD
Buprenorphine—Malaise—Epirubicin—sarcoma	0.000174	0.000867	CcSEcCtD
Buprenorphine—Nervousness—Doxorubicin—sarcoma	0.000174	0.000864	CcSEcCtD
Buprenorphine—Vertigo—Epirubicin—sarcoma	0.000174	0.000864	CcSEcCtD
Buprenorphine—Syncope—Epirubicin—sarcoma	0.000173	0.000863	CcSEcCtD
Buprenorphine—Back pain—Doxorubicin—sarcoma	0.000173	0.000861	CcSEcCtD
Buprenorphine—Muscle spasms—Doxorubicin—sarcoma	0.000172	0.000856	CcSEcCtD
Buprenorphine—Palpitations—Epirubicin—sarcoma	0.000171	0.00085	CcSEcCtD
Buprenorphine—Loss of consciousness—Epirubicin—sarcoma	0.00017	0.000845	CcSEcCtD
Buprenorphine—Cough—Epirubicin—sarcoma	0.000169	0.000839	CcSEcCtD
Buprenorphine—Vision blurred—Doxorubicin—sarcoma	0.000169	0.000839	CcSEcCtD
Buprenorphine—Convulsion—Epirubicin—sarcoma	0.000167	0.000833	CcSEcCtD
Buprenorphine—Nausea—Etoposide—sarcoma	0.000167	0.000832	CcSEcCtD
Buprenorphine—Hypertension—Epirubicin—sarcoma	0.000167	0.00083	CcSEcCtD
Buprenorphine—Ill-defined disorder—Doxorubicin—sarcoma	0.000166	0.000826	CcSEcCtD
Buprenorphine—Myalgia—Epirubicin—sarcoma	0.000165	0.000819	CcSEcCtD
Buprenorphine—Chest pain—Epirubicin—sarcoma	0.000165	0.000819	CcSEcCtD
Buprenorphine—Arthralgia—Epirubicin—sarcoma	0.000165	0.000819	CcSEcCtD
Buprenorphine—Agitation—Doxorubicin—sarcoma	0.000164	0.000818	CcSEcCtD
Buprenorphine—Anxiety—Epirubicin—sarcoma	0.000164	0.000816	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000163	0.000813	CcSEcCtD
Buprenorphine—Discomfort—Epirubicin—sarcoma	0.000163	0.000809	CcSEcCtD
Buprenorphine—Malaise—Doxorubicin—sarcoma	0.000161	0.000803	CcSEcCtD
Buprenorphine—Dry mouth—Epirubicin—sarcoma	0.000161	0.000801	CcSEcCtD
Buprenorphine—Vertigo—Doxorubicin—sarcoma	0.000161	0.0008	CcSEcCtD
Buprenorphine—Syncope—Doxorubicin—sarcoma	0.00016	0.000798	CcSEcCtD
Buprenorphine—Confusional state—Epirubicin—sarcoma	0.000159	0.000792	CcSEcCtD
Buprenorphine—Palpitations—Doxorubicin—sarcoma	0.000158	0.000787	CcSEcCtD
Buprenorphine—Anaphylactic shock—Epirubicin—sarcoma	0.000158	0.000785	CcSEcCtD
Buprenorphine—Oedema—Epirubicin—sarcoma	0.000158	0.000785	CcSEcCtD
Buprenorphine—Loss of consciousness—Doxorubicin—sarcoma	0.000157	0.000782	CcSEcCtD
Buprenorphine—Infection—Epirubicin—sarcoma	0.000157	0.00078	CcSEcCtD
Buprenorphine—Cough—Doxorubicin—sarcoma	0.000156	0.000777	CcSEcCtD
Buprenorphine—Shock—Epirubicin—sarcoma	0.000155	0.000772	CcSEcCtD
Buprenorphine—Convulsion—Doxorubicin—sarcoma	0.000155	0.000771	CcSEcCtD
Buprenorphine—Nervous system disorder—Epirubicin—sarcoma	0.000155	0.00077	CcSEcCtD
Buprenorphine—Hypertension—Doxorubicin—sarcoma	0.000154	0.000768	CcSEcCtD
Buprenorphine—Tachycardia—Epirubicin—sarcoma	0.000154	0.000766	CcSEcCtD
Buprenorphine—Skin disorder—Epirubicin—sarcoma	0.000153	0.000763	CcSEcCtD
Buprenorphine—Hyperhidrosis—Epirubicin—sarcoma	0.000152	0.000759	CcSEcCtD
Buprenorphine—Arthralgia—Doxorubicin—sarcoma	0.000152	0.000758	CcSEcCtD
Buprenorphine—Chest pain—Doxorubicin—sarcoma	0.000152	0.000758	CcSEcCtD
Buprenorphine—Myalgia—Doxorubicin—sarcoma	0.000152	0.000758	CcSEcCtD
Buprenorphine—Anxiety—Doxorubicin—sarcoma	0.000152	0.000755	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000151	0.000752	CcSEcCtD
Buprenorphine—Discomfort—Doxorubicin—sarcoma	0.00015	0.000749	CcSEcCtD
Buprenorphine—Anorexia—Epirubicin—sarcoma	0.00015	0.000748	CcSEcCtD
Buprenorphine—Dry mouth—Doxorubicin—sarcoma	0.000149	0.000741	CcSEcCtD
Buprenorphine—Hypotension—Epirubicin—sarcoma	0.000147	0.000734	CcSEcCtD
Buprenorphine—Confusional state—Doxorubicin—sarcoma	0.000147	0.000732	CcSEcCtD
Buprenorphine—Oedema—Doxorubicin—sarcoma	0.000146	0.000726	CcSEcCtD
Buprenorphine—Anaphylactic shock—Doxorubicin—sarcoma	0.000146	0.000726	CcSEcCtD
Buprenorphine—Infection—Doxorubicin—sarcoma	0.000145	0.000722	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000144	0.000715	CcSEcCtD
Buprenorphine—Shock—Doxorubicin—sarcoma	0.000144	0.000715	CcSEcCtD
Buprenorphine—Nervous system disorder—Doxorubicin—sarcoma	0.000143	0.000712	CcSEcCtD
Buprenorphine—Insomnia—Epirubicin—sarcoma	0.000143	0.00071	CcSEcCtD
Buprenorphine—Tachycardia—Doxorubicin—sarcoma	0.000142	0.000709	CcSEcCtD
Buprenorphine—Skin disorder—Doxorubicin—sarcoma	0.000142	0.000706	CcSEcCtD
Buprenorphine—Paraesthesia—Epirubicin—sarcoma	0.000142	0.000705	CcSEcCtD
Buprenorphine—Hyperhidrosis—Doxorubicin—sarcoma	0.000141	0.000702	CcSEcCtD
Buprenorphine—Dyspnoea—Epirubicin—sarcoma	0.000141	0.0007	CcSEcCtD
Buprenorphine—Somnolence—Epirubicin—sarcoma	0.00014	0.000698	CcSEcCtD
Buprenorphine—Anorexia—Doxorubicin—sarcoma	0.000139	0.000692	CcSEcCtD
Buprenorphine—Dyspepsia—Epirubicin—sarcoma	0.000139	0.000691	CcSEcCtD
Buprenorphine—Decreased appetite—Epirubicin—sarcoma	0.000137	0.000682	CcSEcCtD
Buprenorphine—Hypotension—Doxorubicin—sarcoma	0.000136	0.000679	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000136	0.000678	CcSEcCtD
Buprenorphine—Fatigue—Epirubicin—sarcoma	0.000136	0.000677	CcSEcCtD
Buprenorphine—Constipation—Epirubicin—sarcoma	0.000135	0.000671	CcSEcCtD
Buprenorphine—Pain—Epirubicin—sarcoma	0.000135	0.000671	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000133	0.000662	CcSEcCtD
Buprenorphine—Insomnia—Doxorubicin—sarcoma	0.000132	0.000657	CcSEcCtD
Buprenorphine—Paraesthesia—Doxorubicin—sarcoma	0.000131	0.000652	CcSEcCtD
Buprenorphine—Dyspnoea—Doxorubicin—sarcoma	0.00013	0.000648	CcSEcCtD
Buprenorphine—Feeling abnormal—Epirubicin—sarcoma	0.00013	0.000647	CcSEcCtD
Buprenorphine—Somnolence—Doxorubicin—sarcoma	0.00013	0.000646	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Epirubicin—sarcoma	0.000129	0.000642	CcSEcCtD
Buprenorphine—Dyspepsia—Doxorubicin—sarcoma	0.000128	0.000639	CcSEcCtD
Buprenorphine—Decreased appetite—Doxorubicin—sarcoma	0.000127	0.000631	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000126	0.000627	CcSEcCtD
Buprenorphine—Fatigue—Doxorubicin—sarcoma	0.000126	0.000626	CcSEcCtD
Buprenorphine—Urticaria—Epirubicin—sarcoma	0.000125	0.000624	CcSEcCtD
Buprenorphine—Constipation—Doxorubicin—sarcoma	0.000125	0.000621	CcSEcCtD
Buprenorphine—Pain—Doxorubicin—sarcoma	0.000125	0.000621	CcSEcCtD
Buprenorphine—Abdominal pain—Epirubicin—sarcoma	0.000125	0.000621	CcSEcCtD
Buprenorphine—Body temperature increased—Epirubicin—sarcoma	0.000125	0.000621	CcSEcCtD
Buprenorphine—Feeling abnormal—Doxorubicin—sarcoma	0.00012	0.000599	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000119	0.000594	CcSEcCtD
Buprenorphine—Hypersensitivity—Epirubicin—sarcoma	0.000116	0.000578	CcSEcCtD
Buprenorphine—Urticaria—Doxorubicin—sarcoma	0.000116	0.000577	CcSEcCtD
Buprenorphine—Body temperature increased—Doxorubicin—sarcoma	0.000115	0.000574	CcSEcCtD
Buprenorphine—Abdominal pain—Doxorubicin—sarcoma	0.000115	0.000574	CcSEcCtD
Buprenorphine—Asthenia—Epirubicin—sarcoma	0.000113	0.000563	CcSEcCtD
Buprenorphine—Pruritus—Epirubicin—sarcoma	0.000112	0.000555	CcSEcCtD
Buprenorphine—Diarrhoea—Epirubicin—sarcoma	0.000108	0.000537	CcSEcCtD
Buprenorphine—Hypersensitivity—Doxorubicin—sarcoma	0.000108	0.000535	CcSEcCtD
Buprenorphine—Asthenia—Doxorubicin—sarcoma	0.000105	0.000521	CcSEcCtD
Buprenorphine—Dizziness—Epirubicin—sarcoma	0.000104	0.000519	CcSEcCtD
Buprenorphine—Pruritus—Doxorubicin—sarcoma	0.000103	0.000514	CcSEcCtD
Buprenorphine—Vomiting—Epirubicin—sarcoma	0.0001	0.000499	CcSEcCtD
Buprenorphine—Diarrhoea—Doxorubicin—sarcoma	9.99e-05	0.000497	CcSEcCtD
Buprenorphine—Rash—Epirubicin—sarcoma	9.95e-05	0.000495	CcSEcCtD
Buprenorphine—Dermatitis—Epirubicin—sarcoma	9.94e-05	0.000495	CcSEcCtD
Buprenorphine—Headache—Epirubicin—sarcoma	9.88e-05	0.000492	CcSEcCtD
Buprenorphine—Dizziness—Doxorubicin—sarcoma	9.65e-05	0.00048	CcSEcCtD
Buprenorphine—Nausea—Epirubicin—sarcoma	9.37e-05	0.000466	CcSEcCtD
Buprenorphine—Vomiting—Doxorubicin—sarcoma	9.28e-05	0.000462	CcSEcCtD
Buprenorphine—Rash—Doxorubicin—sarcoma	9.2e-05	0.000458	CcSEcCtD
Buprenorphine—Dermatitis—Doxorubicin—sarcoma	9.19e-05	0.000458	CcSEcCtD
Buprenorphine—Headache—Doxorubicin—sarcoma	9.14e-05	0.000455	CcSEcCtD
Buprenorphine—Nausea—Doxorubicin—sarcoma	8.67e-05	0.000431	CcSEcCtD
